Kymriah

Kymriah is a groundbreaking cancer treatment known as CAR-T cell therapy. It involves modifying a patient's own immune cells—specifically T cells—so they can better recognize and attack cancer cells. The process includes collecting T cells from the patient, engineering them in a lab to target cancer, and then infusing them back into the patient. Kymriah is primarily used for certain types of blood cancers, like acute lymphoblastic leukemia and large B-cell lymphoma. This innovative therapy represents a personalized approach to cancer treatment, aiming to harness the body's immune system to fight the disease more effectively.